CDTX icon

Cidara Therapeutics
CDTX

Overview Fund Activity

51 hedge funds and large institutions have $18.4M invested in Cidara Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
5
Increased
13
Reduced
12
Closed
6
Calls
$18K
Puts
–
Net Calls
+$18K
Net Calls Change
-$59K

Top Buyers

1
GCP
1
GSA Capital Partners
United Kingdom
$429K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.43M
3
VF
3
Virtu Financial
New York
$76K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$2.66M
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$100K

Top Sellers

1
NCM
1
Nantahala Capital Management
Connecticut
$1.23M
2
WFI
2
West Family Investments
California
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$32.7K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$0
5
Invesco
5
Invesco
Georgia
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WFI
51
West Family Investments
California
– -$348K -18,446 Closed
Two Sigma Investments
52
Two Sigma Investments
New York
– -$52.9K -2,805 Closed
Invesco
53
Invesco
Georgia
– -$39.8K -2,111 Closed
SWP
54
Stratos Wealth Partners
Ohio
– -$34.4K -1,824 Closed
FHA
55
Flagship Harbor Advisors
Massachusetts
– -$28.3K -1,501 Closed
Mercer Global Advisors
56
Mercer Global Advisors
Colorado
– -$27K -1,438 Closed
1 2
3